International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
981,945
Fulltext
622,124
PDF
359,821

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	19,949	1,950	21,899
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	16,408	1,794	18,202
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	13,643	1,094	14,737
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	10,686	3,360	14,046
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	9,921	3,787	13,708
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	12,620	939	13,559
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	10,427	2,862	13,289
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	12,515	505	13,020
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	9,725	2,728	12,453
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	10,994	1,141	12,135
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	9,075	2,616	11,691
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	5,814	5,760	11,574
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	7,728	3,833	11,561
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	9,958	1,503	11,461
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	10,090	1,207	11,297
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	10,713	444	11,157
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	10,317	779	11,096
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	9,603	984	10,587
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	8,623	1,945	10,568
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	8,728	1,809	10,537
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	8,414	2,109	10,523
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	6,804	3,514	10,318
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	9,381	878	10,259
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	8,556	1,616	10,172
Letter to Editor Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	7,258	2,902	10,160
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	9,312	817	10,129
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	8,758	1,304	10,062
Case Report Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	5,709	4,009	9,718
Original Article Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019	4,661	5,024	9,685
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	6,885	2,724	9,609
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	5,151	4,441	9,592
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	6,165	3,003	9,168
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	7,529	1,549	9,078
Case Report A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2022	7,922	1,082	9,004
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	6,169	2,539	8,708
Position Paper Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy Full text \| PDF Year: 2019, Volume: 4, Issue: 1, January-April DOI: 10.25259/IJMIO-6-2019	4,845	3,796	8,641
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	4,528	4,077	8,605
Editorial Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun! Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_23_2019	4,773	3,775	8,548
Original Article Outcome in patients of hormone receptor (HR) positive (Her 2) negative metastatic breast cancer treated with palbociclib – A real-world experience Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_24_2021	7,654	846	8,500
Editorial Molecular insights into tumor microenvironment and targeted therapies Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_28_2021	7,099	1,263	8,362
Editorial Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding? Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_8_2019	3,855	4,454	8,309
Original Article Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2021	6,622	1,676	8,298
Editorial Nanobytes Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_11_2021	6,287	1,920	8,207
Review Article Severe acute respiratory syndrome coronavirus 2: Mutations and variants of concern – the Indian scenario Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_14_2021	7,070	1,113	8,183
Original Article *Multiple gene silencing in STAT* pathway in K562 cells** Full text \| PDF Year: 2019, Volume: 4, Issue: 1, January-April DOI: 10.25259/IJMIO-5-2019	4,566	3,489	8,055
Brief Commentary Myths in oncology Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_37_2020	6,121	1,912	8,033
Review Article Molecular targets in urinary bladder cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_4_2022	6,648	1,133	7,781
Original Article Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2019	3,844	3,916	7,760
Review Article Myeloid neoplasms on poly (ADP-ribose) polymerase inhibitor therapy Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2022	6,846	815	7,661
Review Article Molecular genetic changes in gastric carcinoma Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_8_2020	4,683	2,757	7,440

Most Viewed Articles

Driver mutations in oncogenesis

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Editorial board tribute to Dr. Amit Verma

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Immune dynamics of SARS-CoV-2 virus evolution

Nanobytes

Immuno-oncological era of breast cancer: A progressive path to better treatment

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Immuno-oncology of differentiated thyroid cancer

A compendium of population wide DNA methylation profile for oral cancer in India

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

Advances in immunotherapy for metastatic esophageal cancer

Letter to editor

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Metastatic endometrial carcinoma responsive to pembrolizumab

Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India

Breast cancer prognostic tools: A promising Indian option

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

The Cancer Genomic Atlas – “TO CONQUER CANCER”

A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung

Molecular genetics changes in gallbladder carcinoma

Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!

Outcome in patients of hormone receptor (HR) positive (Her 2) negative metastatic breast cancer treated with palbociclib – A real-world experience

Molecular insights into tumor microenvironment and targeted therapies

Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?

Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region

Nanobytes

Severe acute respiratory syndrome coronavirus 2: Mutations and variants of concern – the Indian scenario

Multiple gene silencing in STAT pathway in K562 cells

Myths in oncology

Molecular targets in urinary bladder cancer

Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study

Myeloid neoplasms on poly (ADP-ribose) polymerase inhibitor therapy

Molecular genetic changes in gastric carcinoma

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**

**Multiple gene silencing in STAT pathway in K562 cells**